Intensity-Modulated Radiation Therapy, Pemetrexed Disodium, and Erlotinib Hydrochloride in Treating Patients With Recurrent or Second Primary Head and Neck Cancer

This study is currently recruiting participants.

Verified January 2013 by Comprehensive Cancer Center of Wake Forest University

Sponsor:

Collaborator:

Information provided by (Responsible Party):

Comprehensive Cancer Center of Wake Forest University

ClinicalTrials.gov Identifier:

NCT01580449

First received: April 17, 2012

Last updated: January 25, 2013

Last verified: January 2013

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	August 2013 (Final data collection date for primary outcome measure)